Delivery Order SPE2DR25D2100-SPE2DR26FA1AF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,027.29 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,236.67 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on December 12, 2025, represents a competitive award with no set-aside designation and carries an ultimate completion date of December 15, 2025. The pharmaceutical product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a $52,432.31 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, which is a firm fixed price delivery order with no set-aside designation, was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work...
- The Defense Logistics Agency awarded a delivery order valued at $11,814.85 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and was awarded competitively without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $58,492.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing contract vehicle with the agency. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $38,610.21 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on November 20, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by November 21, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $44,496.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-set-aside competitive award is set to conclude on January 6, 2026, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $13,427.91 to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a $18,224.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded without set-aside provisions and is scheduled for completion on November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1AFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $49,858.85 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and was awarded on January 6, 2026 without set-aside provisions, indicating competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen), serves as a major pharmaceutical distributor to federal military and healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a vast range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements for critical pharmaceutical commodities essential to military treatment facilities and other government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.9k | 1/5/26 |